Member News
![](https://i0.wp.com/investornews.com/wp-content/uploads/2023/11/Coeptis_Therapeutics_Holdings_Inc_lg.jpg?fit=900%2C230&ssl=1)
-
Coeptis Therapeutics to Pursue Phase 2 Program Using Proprietary First-in-Class Allogeneic NK Cell Therapy for the Treatment of Viral Infections
Novel NK cell therapy approach is designed to bolster and replenish the immune system during severe viral infection, which…
-
Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences
February 6, 2024 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is…
-
FuelPositive Accelerating Toward Sustainable Solutions
February 6, 2024 (Source) — FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) (the “Company” or “FuelPositive”), a leading Green…
-
Ucore Welcomes Canadian Government Officials to its Kingston Ontario CDF for an NRCan Funding Announcement
February 5, 2024 (Source) — Ucore Rare Metals Inc. (TSXV: UCU) (OTCQX: UURAF) (“Ucore” or the “Company”) is pleased to host Canadian…
-
Ciscom Corp. Exceeds Earn-Out Target Growth Under 1883713 Ontario Inc. (Inclusive of Prospect Media Group Ltd.) Share Purchase Agreement for 2023 & Announces Stock Option Grants
February 5, 2024 (Source) — Ciscom Corp. (CSE: CISC) (OTCQB: CISCF) (“Ciscom” or “the Company”) is pleased to…
-
Nano One Provides Shareholder Update with Key Objectives for 2024
February 5, 2024 (Source) — (TSX:NANO)(OTC PINK:NNOMF)(Frankfurt:LBMB) Highlights: Commercialization plan on target and advancing with partners. One-Pot process…
-
SunHydrogen and COTEC of South Korea Advance to Next Phase of Production for 1m² Green Hydrogen Panels
February 5, 2024 (Source) — SunHydrogen, Inc. (OTCQB: HYSR), the developer of a breakthrough technology to produce renewable…
-
FendX Technologies Announces Closing of Non-Brokered Private Placement with Strategic Investors and Upsizing
February 2, 2024 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”) a nanotechnology…